Skip to content
Phenomix logo — A pioneering biotech company dedicated to developing groundb...

Phenomix

A pioneering biotech company dedicated to developing groundbreaking therapies for diabetes and hepatitis C.

Founded 2001 Venture round Total: $106.56M Biotechnology, Health Care +1

General Information

Company Name Phenomix
Founded Year 2001
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Phenomix. To contact Phenomix, visit phenomixcorp.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Phenomix compare?

A PDF of Phenomix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Phenomix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Phenomix

Phenomix was a pioneering biotech company with a focus on developing groundbreaking therapies for diabetes and hepatitis C. Founded in 2001 and headquartered in San Diego, the firm aimed to address significant human diseases through innovative therapeutics. Their lead clinical candidate, PHX1149, a DPP4 inhibitor, showed promise as a once-daily oral treatment for type 2 diabetes and was undergoing phase 2 testing. Additionally, the company was working on a program targeting hepatitis C by inhibiting the NS3/4A viral protease. Despite a $5.96M Venture Round investment on 10 March 2010, Phenomix faced financial challenges. Unfortunately, the company had to close down in October 2010 due to its inability to find a partner to finance its clinical trial expenses after Forest Laboratories withdrew support. This serves as a cautionary tale about the inherent risks and uncertainties in the biotech industry, where promising ventures can face significant hurdles in the development and commercialization of novel therapies.

Business keywords: Biotech company, Drug discovery, Therapeutics, Type 2 diabetes, DPP4 inhibitor, Hepatitis C, NS3/4A viral protease, Clinical trials, San Diego, Pharmaceutical research, Innovative therapies, Clinical candidate, Forest Laboratories, Financial partnership, Company closure

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $5.96M -
10 Mar 2010
Series C $55.00M 10
Novartis Venture Fund, Alta Partners +8
08 Mar 2007
Series B $20.00M 6
Alta Partners, Sofinnova Investments +4
29 Apr 2005
Series A $2.00M 4
Alta Partners, Sofinnova Investments +2
20 Jul 2004
Series A $11.60M 4
Alta Partners, Sofinnova Investments +2
30 Jun 2003
Series A $12.00M 7
Alta Partners, GBS Ventures +5
11 Mar 2002

Phenomix Alternatives & Competitors

View All Alternatives
Phenomix vs

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a stron...

Post-IPO Equity
Biotechnology, Health Care
Phenomix vs

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and comme...

Post-IPO Equity
11 employees
Biotechnology, Health Care
Phenomix vs

French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and asso...

Venture round
7 employees
Biotechnology, Pharmaceutical

FAQ About Phenomix

A pioneering biotech company dedicated to developing groundbreaking therapies for diabetes and hepatitis C.
Phenomix was founded in 2001.
Phenomix operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Biotech company, Drug discovery, Therapeutics and Type 2 diabetes.
Phenomix has completed 6 funding rounds, raising a total of $106.56M. The latest funding stage is Venture round.
Top alternatives and competitors to Phenomix include Idenix Pharmaceuticals, Pharmasset, Inc., AdipoPharma SAS, DiObex, Rezolute, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phenomix and Idenix Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phenomix, https://bouncewatch.com/company/phenomix, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout